4BIO Capital Strengthens Advisory Board and Investment
Press Release 4BIO Capital Strengthens Advisory Board and Investment Team Industry veteran and former CEO of Vifor Pharma Abbas Hussain and world...
Source: globenewswire.com
Leszek Lisowski News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Leszek Lisowski. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Leszek Lisowski Today - Breaking & Trending Today
AAV Manufacturing — Overcoming the Challenges of Plasmid DNA, Upcoming Webinar Hosted by Xtalks
Toronto, ON (PRWEB) November 14, 2022 -- AAV manufacturing and other types of advanced therapy production are experiencing challenges associated with their
Source: prweb.com
DiNAQOR Announces Research Collaboration with Children's Medical Research Institute to Develop Novel, Cardiac Specific Capsids
/PRNewswire/ -- DiNAQOR, a genetic medicine platform company focused on addressing severe inherited cardiac diseases, today announced it has entered into a...
Source: prnewswire.com
Logicbio Therapeutics (LOGC) Gets a Buy Rating from Chardan Capital
Markets In a report released today, Geulah Livshits from Chardan Capital reiterated a Buy rating on Logicbio Therapeutics (LOGC – Research Report), with a price target of $20.00. The company’s shares closed last Tuesday at $6.10. According to TipRanks.com, Livshits is a top 100 analyst with an average return of 78.0% and a 71.0% success rate. Livshits covers the Healthcare sector, focusing on stocks such as Iovance Biotherapeutics, Crispr Therapeutics AG, and Intellia Therapeutics. Logicbio Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $17.00. Logi...
Source: markets.co